Rotino Gianluca 4/A
4/A · Kiromic Biopharma, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4/AAmended
Rotino Gianluca
DirectorCSIO
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2020-12-18−4,423→ 0 totalExercise: $8.14From: 2020-12-18Exp: 2030-12-17→ Common Stock (4,423 underlying)
Footnotes (1)
- [F1]This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on January 6, 2021 (the "Original Form 4"). The Reporting Person was not issued the employee stock options (the "December Stock Options") that were noted in the Original Form 4. The "Number of derivative Securities Beneficially Owned" with respect to the December Stock Options is 0.